SAN FRANCISCO & NEW DELHI--(BUSINESS WIRE)--The Institute for OneWorld Health announced today that the story behind Paromomycin IM injection, its groundbreaking treatment for Visceral Leishmaniasis (VL) will be featured on BBC World’s Kill or Cure? series on June 3. OneWorld Health is the first US-based non-profit pharmaceutical company that develops drugs for people with neglected diseases in the developing world.
